## SHW: Sherwin-Williams Company (The) - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 -2.1% below STRENGTH zone (3.0-6.0%); PEG 3.31 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($323.57)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Laurel Wealth Advisors LLC Purchases 1,028 Shares of The Sherwin-Williams Company $SHW**
- Source: MarketBeat | 20251130T113701 | Bullish | Relevance: 99%
- Laurel Wealth Advisors LLC significantly increased its stake in The Sherwin-Williams Company by 34,266.7% in Q2, acquiring an additional 1,028 shares to hold a total of 1,031 shares valued at approximately $354,000. Sherwin-Williams reported strong Q2 earnings, beating analyst expectations with $3.59 EPS and $6.36 billion in revenue, and issued optimistic FY2025 guidance. The company also declared a quarterly dividend and received a "Moderate Buy" consensus rating from analysts with an average price target of $390.87.

**2. The Sherwin-Williams Company (NYSE:SHW) Given Average Rating of "Moderate Buy" by Analysts**
- Source: MarketBeat | 20251130T175224 | Bullish | Relevance: 99%
- The Sherwin-Williams Company (NYSE:SHW) has received a consensus "Moderate Buy" rating from sixteen brokerages, with an average 12-month price target of $390.87. The company recently reported strong Q3 earnings, beating estimates for EPS and revenue, and announced a quarterly dividend of $0.79 per share. Institutional investors hold a significant portion of the stock, with major firms increasing their positions.

**3. Is Sherwin-Williams' (SHW) Extended Credit Maturity Signaling a Shift in Financial Strategy?**
- Source: Simply Wall Street | 20251130T043055 | Somewhat-Bullish | Relevance: 99%
- Sherwin-Williams (SHW) recently extended the maturity of US$75 million in credit commitments from December 2025 to December 2030, enhancing its financial flexibility. This move supports its growth initiatives and shareholder returns, although it doesn't significantly alter the short-term focus on aggressive store expansion nor fully offset supply chain and demand pressures. The article also highlights the company's strong Q3 2025 results and positive long-term revenue and earnings projections.

**4. Sherwin-Williams Stock Prediction: Where Analysts See the Stock Going by 2027**
- Source: TIKR.com | 20251201T205144 | Somewhat-Bullish | Relevance: 98%
- This article analyzes analyst predictions for Sherwin-Williams (NYSE: SHW) stock by 2027, factoring in current trading prices, analyst price targets, and growth outlooks. It highlights modest upside potential based on average estimates, driven by the company's strong franchise, strategic investments, and expected gradual market recovery. The analysis also considers bear case factors such as premium valuation and cyclical headwinds.

**5. Sherwin-Williams (SHW): Evaluating Valuation After Earnings Beat and Suvinil Acquisition Boost Outlook**
- Source: Simply Wall Street | 20251202T023602 | Bullish | Relevance: 98%
- Sherwin-Williams (SHW) reported strong third-quarter earnings and revenue, beating expectations, with an improved outlook following the Suvinil acquisition. While analysts suggest it's undervalued at $341.49 against a $386.52 fair value, the company's P/E ratio of 32.7x is higher than the industry average, prompting a debate on whether the market has fully priced in future growth. The article presents differing views on valuation and potential risks.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 16 ($0.21M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+1.4%)
- Blackrock Inc.: 7.1% (-0.7%)
- State Street Corpora: 6.2% (-0.9%)
- Price (T.Rowe) Assoc: 3.6% (-1.7%)
- Morgan Stanley: 2.9% (+1.8%)

### Key Risks

1. Valuation stretched: PEG 3.3x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- M&A activity or partnership announcements may unlock value.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.31 signals overvaluation risk, limited margin of safety. Forward P/E 26.7x stretched relative to 11% growth. Quality metrics strong (ROE 60%). Balance sheet: $1.1B free cash flow. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $81.3B |
| Beta | 1.24 |
| 52W Range | $308.84 - $379.65 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.31 |
| Forward P/E | 26.7 |
| Current P/E | 29.7 |
| YoY Growth | 11.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.2% to -2.1% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.1pp (needs >3.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. MACD histogram positive (0.88), confirming momentum. RSI neutral at 49.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.13% (CS: 34) | Weak |
| RSI_14 | 48.8 | Neutral |
| MACD Histogram | 0.88 | Bullish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 0.997x | Below |
| vs SMA200 | 0.973x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $337.49
- **Stop Loss:** $323.57 (4.1% risk)
- **Target:** $351.41 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 71
- **Position Value:** $23,961.79
- **Portfolio %:** 23.96%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-03 (Est: $2.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.44 | $3.59 | +4.4% |
| 2025Q2 | $3.81 | $3.38 | -11.2% |
| 2025Q1 | $2.16 | $2.25 | +4.1% |
| 2024Q4 | $2.06 | $2.09 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*